FREE Case Review (866) 588-0600

California Tylenol Autism Lawsuit: Get the Right Attorney

Award Logos
Awards & recognition
C.L. Mike Schmidt Published by C.L. Mike Schmidt

Are you aware of the ongoing legal battle involving Tylenol and its possible link to autism and ADHD in children who were exposed to it prenatally?

If this is new to you, you've come to the right place to learn about the significant California Tylenol autism lawsuit and the potential implications it holds.

At Schmidt & Clark, LLP, we are closely following this groundbreaking case, recognizing its importance to numerous families.

Our team is dedicated to providing updates and insights on this developing situation, helping you understand the potential impact of the California Tylenol autism lawsuit and what it might mean for affected families.

Recent research has indicated that there might be a link between Tylenol use during pregnancy and an increased risk of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in children.

This discovery has resulted in an influx of Tylenol autism lawsuits. These legal claims allege that prenatal exposure to Tylenol results in neurodevelopmental disorders in children.

The Tylenol autism lawsuit has led to multidistrict litigation (MDL). In this process, all Tylenol lawsuits are consolidated under Judge Denise Cote’s jurisdiction, striving to conserve court resources and enhance litigation efficiency.

California Tylenol Autism Lawsuit

The Tylenol autism lawsuit brings attention to the potential risks associated with Tylenol consumption during pregnancy, especially concerning Tylenol autism ADHD lawsuits.

The acetaminophen autism lawsuits allege that companies that produce and distribute Tylenol did not inform consumers of the heightened risks of autism and ADHD in children if taken by their mothers during pregnancy. This lack of warning is what the lawsuit is objecting to.

Currently, 265 Tylenol lawsuits, specifically related to autism and ADHD, are pending in federal court. It is anticipated that approximately 150,000 individuals will initiate a Tylenol autism ADHD lawsuit within the next two years, with both federal and state cases being combined to ensure judicial efficiency.

In April, the court denied Johnson & Johnson’s motion to dismiss on the grounds of FDA preemption.

Scientific Groundwork: Linking Tylenol to Neurodevelopmental Issues

Various studies, including 26 epidemiological studies and animal studies, attest to the causal link between Tylenol exposure in utero and developmental disorders. Ethical considerations prevent researchers from conducting in-depth studies on pregnant women.

However, animal studies have consistently shown that exposure to acetaminophen in utero may cause significant developmental delays in the fetal brain.

A 2018 meta-analysis, published in the American Journal of Epidemiology, demonstrated a connection between in-utero exposure to acetaminophen and risks believed to be linked with attention deficit hyperactivity disorder (ADHD).

It increased the likelihood by 34%, autism by 19%, and hyperactivity symptoms by 24%. The increased risk of neurodevelopmental disorders, including Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder, has been noted in Tiffany Rutledge’s complaint as well.

In California, the Tylenol autism lawsuits, including those in the class action lawsuit, have been integrated into the multidistrict litigation (MDL) process. This consolidation under Judge Cote's jurisdiction aims to streamline the handling of these cases.

For those looking to join the MDL, it's essential to utilize the short-form complaint as mandated by the court. This ensures that all claims are formatted consistently, aiding in the efficient management of the lawsuit.

In the context of this broader lawsuit, motions to dismiss have been submitted by retailers such as Walmart and Target in the California Tylenol autism lawsuit. This development is part of the larger legal proceedings surrounding the Tylenol lawsuit.

A significant step was taken in January 2023 when Judge Cote ordered a plan for evidence discovery. This plan is focused primarily on the scientific evidence related to causation, particularly the potential link between prenatal acetaminophen exposure and autism spectrum disorders (ASD) or attention deficit hyperactivity disorder (ADHD).

The goal of this plan is to enhance the efficiency of the legal process and expedite the resolution of these cases. Addressing some common questions about the lawsuit, the average payout for Tylenol autism lawsuits is estimated to be between $150,000 and $500,000.

This range depends on the severity of the autism level diagnosed in each case. As for the timeline, the settlement of the Tylenol autism lawsuit is anticipated to occur in 2024, with expectations of significant payouts and the potential addition of a new warning label for Tylenol to protect unborn children.

For individuals looking to prove that they took Tylenol during pregnancy, evidence such as bank statements, credit card bills, and purchase receipts showing the purchase of Tylenol, along with medical records confirming an autism diagnosis in their child, is necessary. This evidence is crucial to substantiate the claim and participate effectively in the lawsuit.

Navigating this legal landscape in California involves understanding these developments and the requirements for participating in the MDL, including the need for consistent claim formatting and the importance of solid evidence to support each case.

Client Guidance: Filing a Lawsuit in California

If you’re thinking about filing a Tylenol autism lawsuit, the initial step involves consulting a certified attorney. A qualified attorney will assist in the collection of medical records and other pertinent evidence necessary for filing a claim and submitting the appropriate short-form complaint as mandated by the court.

To file a Tylenol autism lawsuit, you’ll require:

  • Medical records that confirm the ADHD or ASD diagnosis
  • Proof of Tylenol or generic acetaminophen consumption during pregnancy. This evidence could include medical records showing the use of Tylenol for pregnancy-related pain.
  • The Plaintiff Fact Sheet, a form that contains queries regarding the eligibility and medical history of the plaintiff, must be completed.

Statute of Limitations

The statute of limitations in California is calculated according to the type of case or procedure, with the range extending from one year to 10 years.

Personal injury cases generally have a two-year statute of limitations from the date of the injury; however, there are exceptions and particular regulations for different types of claims, such as California’s discovery rule, which stipulates that the two-year statute of limitations will not commence until the victim is aware or should have been aware of their injuries.

You should consult a legal expert to determine the precise statute of limitations applicable to your case.

Related Articles:

See all related dangerous drug lawsuits our lawyers covered so far.